ANNUAL REPORT FY2024 41 Consolidated statement of profit or loss and other comprehensive income For the year ended 30 June 2024 2024 2023 Note $ $ Revenue Other income 5 176,014 148,817 R&D grant revenue 6 3,226,924 1,429,905 Total revenue 3,402,938 1,578,722 Expenses Employee benefits expense - share based payments (358,074) (541,214) Professional services expenses (477,948) (409,523) Employee benefits expense (1,127,500) (1,100,136) Depreciation and amortisation expense (5,183) (6,534) Research and development costs (2,030,502) (6,411,264) Other expenses (217,198) (250,626) Corporate and administration expenses (577,842) (641,117) Total expenses (4,794,247) (9,360,414) Loss before income tax expense (1,391,309) (7,781,692) Income tax expense - - Loss after income tax expense for the year attributable to the owners of Nyrada Inc. (1,391,309) (7,781,692) Other comprehensive income for the year, net of tax - - Total comprehensive income for the year attributable to the owners of Nyrada Inc. (1,391,309) (7,781,692) Cents Cents Basic loss per share 18 (0.85) (4.99) Diluted loss per share 18 (0.85) (4.99) The above consolidated statement of profit or loss and other comprehensive income should be read in conjunction with the accompanying notes.
RkJQdWJsaXNoZXIy MjE2NDg3